cellbas
therapi
embryon
adult
stem
cell
includ
induc
pluripot
stem
cell
emerg
potenti
novel
approach
sever
devast
otherwis
incur
lung
diseas
includ
emphysema
pulmonari
fibrosi
pulmonari
hypertens
acut
respiratori
distress
syndrom
although
initi
studi
suggest
engraft
exogen
administ
stem
cell
lung
gener
felt
rare
occurr
uncertain
physiolog
signific
howev
recent
studi
demonstr
paracrin
effect
administ
cell
includ
stimul
angiogenesi
modul
local
inflammatori
immun
respons
mous
lung
diseas
model
base
studi
safeti
initi
efficaci
data
trial
adult
stem
cell
diseas
groundbreak
clinic
trial
cellbas
therapi
initi
pulmonari
hypertens
chronic
obstruct
pulmonari
diseas
parallel
ident
role
endogen
lung
progenitor
cell
develop
repair
injuri
potenti
contribut
lung
cancer
stem
cell
continu
elucid
recent
novel
bioengin
approach
appli
develop
function
lung
tissu
ex
vivo
advanc
area
describ
review
particular
refer
anim
model
mani
lung
diseas
remain
incur
continu
substanti
morbid
mortal
includ
chronic
obstruct
pulmonari
diseas
notabl
emphysema
major
diseas
categori
increas
preval
one
lead
caus
death
worldwid
well
less
common
equal
devast
diseas
pulmonari
fibrosi
cystic
fibrosi
pulmonari
hypertens
acut
respiratori
distress
syndrom
ard
although
symptomat
care
condit
improv
lung
transplant
remain
option
mani
patient
howev
sever
shortag
donor
lung
thu
mani
patient
wait
list
die
prior
transplant
furthermor
lung
transplant
often
poor
option
five
year
mortal
approxim
mani
problem
associ
requir
lifelong
immunosuppress
new
option
thu
desper
need
recent
find
embryon
stem
cell
stem
cell
deriv
adult
tissu
might
util
repair
regener
injur
diseas
tissu
stimul
extens
investig
whether
approach
could
util
lung
diseas
parallel
increas
understand
ident
role
endogen
progenitor
cell
lung
includ
possibl
role
lung
cancer
stem
cell
excit
rapidli
move
field
hold
promis
improv
understand
lung
biolog
potenti
therapeut
approach
lung
diseas
review
highlight
recent
advanc
understand
endogen
lung
progenitor
cell
follow
respect
consider
embryon
adultderiv
stem
cell
particular
focu
advanc
cell
therapi
approach
specif
lung
diseas
adult
stem
cell
summar
tabl
undifferenti
multipot
endogen
tissu
stem
cell
identifi
nearli
tissu
thought
contribut
tissu
mainten
repair
rare
unspeci
cell
often
local
special
nich
within
tissu
usual
cycl
infrequ
importantli
exhibit
selfrenew
capac
give
rise
daughter
progenitor
transit
amplifi
cell
stem
progenitor
cell
may
give
rise
differenti
cell
organ
lung
complex
organ
compos
differ
differenti
cell
type
figur
identif
endogen
progenitor
cell
challeng
clear
differ
progenitor
cell
popul
local
differ
anatom
region
lung
alveoli
surfact
produc
type
alveolar
epitheli
cell
aec
well
recogn
progenitor
type
aec
airway
differ
put
airway
progenitor
cell
popul
hierarchi
identifi
along
tracheobronchi
tree
mous
model
follow
select
ablat
epitheli
cell
exposur
toxic
chemic
cell
typespecif
express
celltox
gene
transgen
mice
figur
trachea
larg
airway
larg
airway
submucos
gland
subpopul
basal
epitheli
cell
express
cytokeratin
implic
mice
predomin
epitheli
cell
smaller
airway
noncili
clara
cell
exhibit
characterist
transitamplifi
cell
follow
injuri
ciliat
airway
epitheli
cell
howev
unlik
transitamplifi
cell
tissu
higher
rate
epitheli
turnov
intestin
clara
cell
exhibit
low
prolif
frequenc
steadyst
broadli
distribut
throughout
bronchiolar
epithelium
contribut
special
tissu
function
distal
airway
cell
resist
epitheli
toxin
naphthalen
poison
cytochrom
isozym
found
clara
cell
result
desquam
differenti
airway
epitheli
line
term
toxinresist
variant
clara
cell
identifi
progenitor
function
term
bronchiolar
stem
cell
review
naphthaleneresist
cell
also
locat
within
discret
microenviron
within
bronchiol
includ
neuroepitheli
bodi
neb
bronchoalveolar
duct
junction
badj
review
bronchoalveolar
duct
junction
mous
lung
popul
naphthaleneresist
cell
stain
clara
cell
marker
clara
cell
secretori
protein
ccsp
type
aec
marker
prosurfact
protein
c
prospc
describ
although
rare
cell
prolifer
respons
naphthalen
injuri
also
compensatori
lung
growth
follow
unilater
pneumonectomi
mice
prospcccsp
dual
posit
cell
isol
use
method
develop
enrich
type
aec
dual
label
cell
exhibit
uniqu
cell
surfac
phenotyp
cell
found
selfrenew
cultur
give
rise
progeni
express
ccsp
prospc
type
aec
marker
aquaporin
cell
term
bronchioalveolar
stem
cell
basc
howev
depend
techniqu
util
ambigu
publish
result
toxinresist
clara
cell
basc
cell
may
repres
differ
interpret
cell
popul
highlight
need
specif
marker
differ
cell
popul
rigor
method
lineag
trace
well
underscor
import
vivo
microenviron
cell
behavior
exampl
express
stem
cell
thought
featur
murin
hematopoiet
cell
describ
marker
put
bronchiolar
progenitor
cell
well
fibroblast
progenitor
cell
lung
recent
data
util
chimer
wildtypegfp
chimer
mice
gener
implant
cell
gfp
mous
embryo
aggreg
pseudopregn
wildtyp
femal
demonstr
bronchiolar
progenitor
cell
appear
play
role
normal
airway
epitheli
homeostasi
turnov
particip
set
lung
injuri
less
inform
avail
concern
potenti
progenitor
cell
popul
contribut
cell
popul
interstiti
smooth
muscl
endotheli
cell
lung
recent
sever
group
identifi
appear
resid
mesenchym
stromal
stem
cell
mous
lung
well
neonat
adult
human
lung
present
unclear
whether
cell
may
particip
structur
repair
lung
tissu
may
play
role
immun
surveil
immunomodul
addit
role
endogen
lung
stem
progenitor
cell
repair
lung
injuri
increas
inform
suggest
matur
differenti
lung
cell
may
transdifferenti
chang
phenotyp
best
describ
epithelialmesenchym
transit
recent
investig
describ
wider
rang
revers
phenotyp
epitheli
mucu
cell
mechan
may
also
play
signific
role
injuri
repair
injuri
thu
overal
although
progress
made
clarifi
ident
role
airway
progenitor
cell
mice
role
cell
popul
remain
unclear
moreov
littl
correspond
data
yet
exist
anim
model
human
lung
although
attract
specul
failur
normal
endogen
airway
stem
cell
repar
function
may
contribut
chronic
acquir
lung
diseas
emphysema
evid
remain
sketchi
present
suggest
inform
avail
genet
lung
diseas
cystic
fibrosi
cf
airway
epithelium
cf
patient
contain
primit
cuboid
cell
express
primit
cell
marker
includ
thyroid
transcript
factor
cytokeratin
neuroepitheli
cell
also
express
cystic
fibrosi
transmembran
conduct
regul
protein
cftr
defect
protein
patient
cf
appear
play
role
neuropeptid
secret
cftr
mice
also
contain
fewer
pulmonari
neuroendocrin
cell
embryon
develop
increas
number
cell
postnat
suggest
endogen
airway
progenitor
cell
pathway
cf
lung
may
alter
extens
investig
recent
anoth
popul
put
airway
progenitor
cell
express
ccsp
stem
cell
antigen
stage
specif
embryon
antigen
embryon
stem
cell
marker
identifi
neonat
mice
cell
abl
form
epitheli
coloni
differenti
type
type
alveolar
epitheli
cell
interestingli
cell
suscept
infect
sar
sever
acut
respiratori
syndrom
viru
rais
possibl
endogen
lung
progenitor
cell
may
specif
diseas
target
compar
basal
epitheli
cell
trachea
upper
airway
appear
suscept
infect
common
cold
rhinoviru
endogen
progenitor
cell
may
also
attract
candid
target
gene
transfer
vector
provid
sustain
express
variant
clara
cell
appear
specif
target
recombin
adenoassoci
vector
adult
mice
possibl
remain
endogen
stem
progenitor
popul
exist
much
room
addit
inform
regulatori
mechan
pathway
elucid
epitheli
progenitor
cell
popul
intens
current
interest
connect
endogen
stem
progenitor
cell
cancer
stem
cell
cancer
stem
cell
defin
transplant
assay
critic
cell
tumor
capabl
propag
diseas
hypothes
cell
maintain
tumor
progress
diseas
resist
best
describ
breast
solid
cancer
increas
evid
suggest
may
multipl
lung
cancer
stem
cell
given
heterogen
lung
cancer
may
surpris
basc
suggest
role
develop
lung
cancer
mice
role
tumor
mainten
establish
human
correl
demonstr
side
popul
cell
identifi
sever
human
lung
cancer
cell
line
exhibit
tumorigen
properti
subcutan
implant
nod
scid
mice
side
popul
cell
also
identifi
clinic
lung
cancer
specimen
number
recent
report
implic
cell
confer
resist
chemotherapi
tumor
initi
properti
lung
cancer
recent
studi
begun
elucid
cell
signal
gene
express
pathway
includ
wnt
hedgehog
ckit
akt
other
may
play
role
transform
endogen
progenitor
cell
lung
cancer
cell
despit
grow
data
work
need
clarifi
connect
endogen
lung
progenitor
cell
potenti
role
lung
cancer
stem
cell
determin
potenti
role
therapeut
target
progress
util
esc
lung
regener
repair
slower
develop
studi
past
approxim
year
sever
laboratori
demonstr
mous
human
esc
induc
cultur
acquir
phenotyp
marker
type
aec
includ
express
surfact
protein
lamellar
bodi
even
form
pseudoglandular
structur
gener
occur
low
level
unless
esc
genet
engin
select
surfact
proteinexpress
cell
recent
protocol
manipul
cell
signal
pathway
guid
embryolog
lung
develop
develop
definit
endoderm
yield
robust
vitro
deriv
cell
phenotyp
characterist
type
alveolar
epitheli
cell
murin
esc
figur
deriv
airway
epitheli
cell
esc
proven
even
elus
although
develop
cell
phenotyp
marker
airway
epitheli
cell
demonstr
follow
cultur
esc
airliquid
interfac
condit
moreov
still
limit
avail
studi
effect
esc
administr
lung
vivo
endotrach
administr
mescderiv
type
aec
fetal
mice
result
surviv
cell
lung
mainten
prospc
express
hour
period
whether
cell
truli
engraft
function
signific
determin
recent
transduct
one
approv
human
esc
line
develop
univers
wisconsin
line
spcpromoterdriven
neomycin
express
cassett
util
develop
pure
popul
escderiv
cell
phenotyp
characterist
type
aec
includ
surfact
express
presenc
lamellar
bodi
hesatii
intratrach
administr
hesatii
cell
day
follow
induct
acut
lung
injuri
follow
intratrach
bleomycin
administr
immunocompromis
scid
mice
result
substanti
number
hesatii
cell
appear
engraft
lung
persist
spc
express
day
later
total
spcexpress
cell
appear
hesatii
origin
small
number
hesatii
cell
also
appear
differenti
type
aec
vivo
appar
engraft
observ
hesatii
cell
administ
uninjur
mice
control
monocyt
popul
administ
parallel
bleomycin
induc
lung
injuri
significantli
reduc
mice
receiv
hesatii
cell
monocyt
vehicl
control
reduc
injuri
measur
qualit
quantit
measur
includ
function
measur
tidal
volum
arteri
oxygen
satur
whether
observ
amelior
lung
injuri
result
structur
engraft
administ
cell
reflect
previous
unsuspect
paracrin
effect
hesderiv
cell
yet
clear
nonetheless
result
number
ramif
includ
studi
potenti
use
esc
genet
lung
diseas
human
embryon
stem
cell
line
establish
england
belgium
cell
exhibit
normal
morpholog
protein
express
compar
he
cell
line
studi
detail
new
loosen
restrict
studi
human
esc
unit
state
anticip
rapid
advanc
studi
esc
lung
injuri
repair
initi
specul
adult
bone
marrowderiv
cell
includ
hematopoiet
stem
cell
hsc
mesenchym
stromal
stem
cell
msc
endotheli
progenitor
cell
epc
circul
fibrocyt
popul
could
structur
engraft
matur
differenti
airway
alveolar
epitheli
cell
vascular
endotheli
interstiti
lung
cell
sizeabl
literatur
develop
past
approxim
year
predominantli
base
studi
mice
util
techniqu
evalu
histolog
demonstr
tag
donorderiv
marrow
cell
recipi
lung
follow
system
intratrach
administr
tag
donor
marrow
cell
experiment
approach
includ
use
donor
marrow
cell
transgen
green
fluoresc
protein
gfp
express
mice
use
sexmismatch
transplant
ie
male
donor
cell
femal
recipi
subsequ
identif
donor
cell
util
fluoresc
situ
hybrid
fish
detect
chromosom
review
lethal
irradi
myeloabl
recipi
mous
bone
marrow
prior
cell
administr
frequent
alway
util
notabl
prior
lung
injuri
includ
radiationinduc
lung
injuri
result
myeloabl
total
bodi
irradi
usual
requir
observ
engraft
although
lung
injuri
alway
result
appar
increas
engraft
howev
becom
appar
engraft
exogen
administ
adult
stem
cell
airway
alveolar
epitheli
cell
gener
rare
occurr
uncertain
physiolog
signific
sever
technic
issu
contribut
misinterpret
result
earlier
report
includ
inadequ
microscop
techniqu
donorderiv
cell
superimpos
resid
airway
alveolar
epitheli
cell
effect
discrimin
varieti
leukocyt
notabl
airway
alveolar
macrophag
resid
lung
mani
earli
report
util
antibodi
direct
leukocyt
marker
exclud
possibl
cell
donor
origin
detect
airway
alveolar
epithelium
donorderiv
leukocyt
rather
epitheli
cell
tool
detect
gfp
direct
fluoresc
marker
donorderiv
marrow
cell
subject
error
presenc
autofluoresc
cell
resid
lung
notabl
alveolar
macrophag
fusion
marrowderiv
cell
resid
organ
cell
rather
phenotyp
convers
marrow
cell
demonstr
sever
organ
notabl
liver
skelet
muscl
also
lung
extent
fusion
lung
follow
sexmismatch
transplant
may
underestim
chromosom
may
lost
heterokaryon
cell
result
fusion
donorderiv
marrow
cell
type
alveolar
epitheli
cell
mous
lung
smaller
bodi
literatur
human
bone
marrow
lung
transplant
also
demonstr
appar
chimer
lung
transplant
recipi
also
call
question
reason
review
nonetheless
recent
studi
rigor
techniqu
continu
demonstr
engraft
airway
alveolar
epithelium
well
pulmonari
vascular
endothelium
lung
interstitium
adult
bone
marrow
cord
bloodderiv
stem
cell
although
rare
occur
certain
condit
usual
follow
previou
perturb
induct
lung
injuri
interestingli
sever
recent
report
suggest
chronic
progress
lung
injuri
may
result
substanti
engraft
type
aec
interstiti
pulmonari
vascular
cell
donorderiv
cell
mous
rat
model
howev
chronic
lung
injuri
model
result
substanti
epitheli
engraft
notabl
engraft
pulmonari
vascular
endothelium
stimul
neoangiogenesi
exogen
administ
endotheli
progenitor
cell
epc
foster
recent
clinic
trial
treatment
pulmonari
hypertens
discuss
howev
mani
variabl
still
left
explor
may
increas
epitheli
interstiti
pulmonari
vascular
engraft
circul
donorderiv
cell
exampl
type
marrowderiv
cord
bloodderiv
fulli
differenti
nonpulmonari
cell
might
engraft
lung
epithelium
interstitium
pulmonari
vasculatur
remain
fulli
explor
addit
exist
studi
hsc
msc
bone
marrow
cord
blood
origin
epc
fibrocyt
possibl
remain
may
cell
popul
could
recruit
lung
local
lung
follow
system
rout
administr
popul
circul
bone
marrowderiv
cell
describ
particip
reepitheliaz
denud
tracheal
xenograft
recent
popul
ccspexpress
marrow
cell
suggest
engraft
airway
epithelium
sourc
stem
progenitor
cell
umbil
cord
blood
adipos
tissu
also
yet
extens
character
abil
engraft
lung
tissu
effect
age
either
donor
cell
recipi
also
less
well
explor
although
one
report
demonstr
transplant
whole
marrow
oneday
old
mous
pup
use
varieti
condit
regimen
increas
number
bone
marrowderiv
cell
observ
follow
total
marrow
administr
adult
mice
furthermor
rout
administr
donorderiv
cell
less
well
character
studi
investig
engraft
follow
system
administr
donor
cell
direct
intratrach
administr
msc
may
enhanc
retent
donorderiv
cell
lung
possibl
epitheli
engraft
howev
area
controversi
remain
underexplor
abil
structur
engraft
adult
lung
may
sole
properti
stem
progenitor
cell
exampl
intratrach
administr
isol
type
alveolar
epitheli
cell
result
rare
engraft
area
injur
lung
follow
bleomycin
administr
rat
notabl
bleomycininjur
rat
receiv
type
aec
less
histolog
injuri
decreas
hydroxyprolin
content
compar
intratrach
administr
neonat
mous
lung
fibroblast
result
appar
alveolar
interstiti
engraft
engraft
higher
area
elastaseinduc
lung
injuri
system
administ
skin
fibroblast
transduc
ex
vivo
express
protect
lung
injuri
produc
intratrach
endotoxin
administr
rat
result
suggest
lung
injuri
might
amen
cell
therapi
approach
util
varieti
cell
type
stem
progenitor
cell
mechan
circul
system
administ
stem
progenitor
cell
might
recruit
lung
remain
poorli
understood
follow
system
ie
venou
administr
mani
cell
initi
local
lung
first
major
capillari
bed
encount
lung
injuri
result
increas
local
andor
retent
marrowderiv
cell
lung
rang
ident
chemotact
solubl
mediat
releas
injur
lung
cell
role
upregul
adhes
molecul
circul
cell
might
interact
remain
poorli
understood
sever
recogn
pathway
includ
axi
also
appear
involv
review
recipi
immun
respons
also
play
signific
yet
poorli
character
role
retent
cell
lung
commonli
util
approach
sexmismatch
transplant
cell
administr
may
also
result
clearanc
cell
time
cell
administr
lung
injuri
also
influenc
recruit
phenotyp
convers
system
administr
msc
four
hour
lung
irradi
result
appar
engraft
cell
epitheli
vascular
endotheli
cell
howev
msc
administ
later
time
point
appear
engraft
interstiti
cell
particip
develop
fibrosi
engraft
number
factor
includ
age
donor
recipi
type
cell
administ
rout
administr
might
affect
recruit
lung
lodg
recruit
lung
mechan
stem
progenitor
cell
might
induc
acquir
phenotyp
lung
epitheli
interstiti
vascular
endotheli
cell
remain
poorli
understood
vitro
studi
continu
demonstr
solubl
factor
releas
lung
epitheli
cell
injur
lung
homogen
induc
express
lung
epitheli
marker
sever
type
marrowderiv
cell
possibl
activ
signal
pathway
one
novel
mechan
induc
phenotyp
chang
might
involv
releas
membranederiv
microvesicl
recent
appreci
mean
intercellular
commun
involv
horizont
transfer
mrna
protein
cell
msc
first
describ
adher
clonogen
nonphagocyt
fibroblasticlik
popul
bone
marrow
cell
sinc
isol
mani
tissu
includ
adipos
tissu
cord
blood
placenta
amniot
fluid
msc
multipot
differenti
cell
mesoderm
endoderm
ectoderm
lineag
cell
also
abil
regul
hematopoiet
cell
secret
multipl
regulatori
molecul
growth
factor
antiinflammatori
cytokin
modul
immun
respons
mechan
msc
action
inflammatori
immun
cell
well
understood
like
involv
secret
solubl
mediat
well
cellcel
contact
figur
although
frequenc
msc
adult
bone
marrow
low
less
isol
msc
expand
ex
vivo
make
possibl
manufactur
cell
potenti
therapeut
purpos
msc
easili
transduc
genet
manipul
deliv
secret
select
diseasemodifi
molecul
moreov
msc
also
seem
rel
immunoprivileg
due
low
constitut
express
major
histocompat
complex
mhc
type
lack
constitut
express
mhc
type
costimulatori
molecul
allow
administr
allogen
msc
without
signific
host
respons
overal
properti
msc
make
attract
therapeut
tool
vector
treatment
deliveri
immunomodulatori
agent
msc
util
clinic
trial
inflammatori
autoimmun
diseas
graft
vs
host
crohn
diseas
well
acut
myocardi
infarct
discuss
immunomodul
amelior
lung
injuri
demonstr
varieti
mous
model
suggest
direct
translat
rout
toward
clinic
trial
cell
therapi
lung
diseas
trial
allogen
msc
patient
moderatesever
chronic
obstruct
pulmonari
diseas
start
unit
state
grow
number
studi
demonstr
compel
data
benefici
effect
msc
mous
model
ali
includ
acut
bacteri
pneumonia
administr
endotoxin
bleomyicn
hyperoxia
exposur
cecal
ligat
punctur
clp
induc
sepsi
avail
anim
model
acut
lung
injuri
ali
use
evalu
pathogenesi
pathophysiolog
lung
injuri
acidinduc
acut
lung
injuri
ventilatorinduc
lung
injuri
howev
none
yet
test
therapeut
efficaci
msc
endotoxin
injuri
model
mice
receiv
escherichia
coli
lp
either
via
intraperiton
intratrach
follow
msc
administr
system
intratrach
hour
hour
follow
injuri
respect
lp
administr
result
acut
lung
inflamm
begin
sever
hour
peak
hour
resolv
system
intrapulmonari
administr
bone
marrowderiv
msc
demonstr
result
improv
mortal
improv
alveolar
fluid
clearanc
attenu
inflamm
lung
injuri
despit
minim
engraft
msc
lung
sever
paracrin
mechan
propos
msc
effect
model
includ
releas
antiinflammatori
mediat
keratinocyt
growth
factor
kgf
moreov
msc
engin
express
potenti
protect
effect
msc
msc
may
influenc
specif
inflammatori
environ
injur
lung
exampl
endotoxin
act
tolllik
receptor
express
msc
result
increas
product
subsequ
increas
product
antiinflammatori
agent
prostaglandin
msc
similar
antiinflammatori
effect
msc
found
endotoxintr
isol
perfus
human
lung
anoth
interest
studi
perform
zhao
et
al
show
protect
lung
injuri
prevent
endotheli
leakag
strengthen
endotheli
adher
junction
barrier
activ
rhogtpas
altogeth
studi
demonstr
potent
immunomodulatori
effect
msc
mous
isol
human
lung
model
acut
lung
injuri
provid
import
preclin
data
potenti
clinic
trial
allogen
msc
ali
ard
idiopath
pulmonari
fibrosi
ipf
devast
chronic
progress
pulmonari
diseas
high
morbid
mortal
effect
treatment
diseas
identifi
ipf
consid
caus
proinflammatori
noninflammatori
pathway
lead
chronic
epitheli
injuri
trigger
cellular
apoptosi
dysregul
immun
respons
character
among
thing
elicit
cytokin
promot
express
profibrot
factor
like
transform
growth
factor
beta
fibrot
lung
diseas
consequ
underli
autoimmun
inflammatori
condit
yet
unclear
mechan
sever
anim
model
fibrot
lung
diseas
develop
studi
pathophysiolog
pathogenesi
human
fibrot
lung
diseas
best
character
model
bleomycin
model
pulmonari
fibrosi
drug
initi
use
antineoplast
agent
howev
use
limit
pulmonari
toxic
develop
pulmonari
fibrosi
administ
via
intraperiton
intraven
subcutan
intratrach
rout
fibrot
lung
diseas
model
character
fitcinduc
fibrosi
irradiationinduc
fibrosi
silica
asbestosinduc
fibrosi
variou
transgen
mice
includ
tbet
defici
mice
viral
model
chronic
fibrosi
murin
model
extens
evalu
protect
therapeut
effect
msc
fibrot
lung
diseas
intratrach
administr
bleomycin
advantag
model
requir
singl
dose
result
injuri
fibrosi
fibrosi
start
around
day
maxim
respons
around
day
howev
resolut
fibrosi
occur
mice
day
system
administr
msc
hour
follow
bleomycin
administr
demonstr
reduc
inflamm
fibrosi
format
mortal
day
follow
injuri
part
mediat
receptor
antagonist
releas
msc
howev
protect
effect
msc
abrog
msc
given
day
injuri
anoth
studi
util
asbestosinduc
pulmonari
fibrosi
mice
follow
total
bodi
irradi
bone
marrow
transplant
chimer
mice
protect
develop
lung
injuri
fibrosi
compar
nonchimer
mice
howev
protect
effect
transplant
like
due
chang
occur
follow
irradi
bone
marrow
transplant
anoth
studi
demonstr
reduct
collagen
deposit
bleomycininduc
lung
fibrosi
mice
follow
administr
msc
lineag
neg
lin
hsc
engin
overexpress
kgf
contrast
anoth
bone
marrowderiv
stem
cell
popul
circul
fibrocyt
implic
pathogenesi
sever
lung
diseas
mous
clinic
model
includ
pulmonari
fibrosi
pulmonari
hypertens
subepitheli
fibrosi
develop
sever
asthma
clinic
bronchiol
obliteran
lung
bone
marrow
transplant
patient
level
circul
fibrocyt
may
indic
wors
prognosi
asthma
ipf
base
current
avail
data
mous
model
cellbas
therapi
approach
may
less
effect
establish
fibrot
lung
diseas
howev
studi
util
cell
therapi
prevent
modal
develop
fibrosi
ie
follow
irradiationinduc
lung
injuri
need
exampl
administ
marrowderiv
cell
earli
radiationinduc
lung
injuri
mice
protect
wherea
administ
cell
later
result
cell
contribut
radiationinduc
damag
one
potenti
therapeut
avenu
fibrot
lung
diseas
inhibit
fibrocyt
altern
cell
might
excel
vector
deliv
therapeut
agent
directli
site
fibrosi
ie
fibroblast
foci
copd
current
fourth
lead
caus
death
worldwid
approxim
patient
copd
present
emphysema
character
destruct
termin
bronchiol
alveolar
wall
caus
enlarg
air
space
patient
gener
die
progress
respiratori
failur
despit
advanc
symptomat
treatment
emphysema
remain
cure
avail
experiment
mous
model
emphysema
includ
transgen
knockout
model
exposur
environment
agent
tobacco
smoke
intratrach
administr
degrad
enzym
elastas
sever
studi
evalu
role
stem
cell
remodel
lung
mous
emphysema
model
util
elastasetr
transgen
tightskin
tsk
mice
studi
util
transplant
wild
type
mous
bone
marrow
cell
emphysemat
mice
demonstr
decreas
emphysemat
structur
chang
chimer
mice
particular
studi
tsk
mice
alreadi
develop
emphysemat
chang
time
transplant
demonstr
revers
chang
lung
resembl
agecontrol
normal
mice
nonsignific
engraft
donorderiv
cell
chimer
mice
anoth
studi
rat
done
specif
evalu
role
bone
marrow
stromal
cell
irradi
papaininduc
emphysema
studi
plastic
adher
bone
marrow
cell
bone
marrowderiv
stromal
cell
system
administ
immedi
follow
irradi
gy
total
bodi
irradi
intratrach
instil
papain
bodi
weight
lung
harvest
day
demonstr
reduct
airspac
enlarg
quantifi
mean
linear
intercept
apoptot
cell
bone
marrowderiv
stromal
cell
treat
group
compar
control
irradi
papaintr
group
minim
engraft
donorderiv
cell
observ
data
suggest
bone
marrowderiv
stromal
cell
protect
progress
emphysema
potenti
mechan
like
paracrin
effect
result
decreas
alveolar
apoptosi
follow
injuri
howev
much
yet
learn
antiinflammatori
effect
bone
marrowderiv
stem
cell
popul
model
copd
phase
doubleblind
placebocontrol
trial
prochymaltm
ex
vivo
cultur
adult
human
mesenchym
stem
cell
conduct
osiri
therapeut
inc
columbia
md
patient
acut
myocardi
infarct
improv
fvc
note
treat
patient
mechan
improv
pulmonari
function
patient
popul
yet
well
understood
observ
stimul
multicent
doubleblind
placebocontrol
phase
ii
trial
prochymaltm
osiri
therapeut
inc
columbia
md
patient
moderatesever
copd
initi
may
primari
goal
trial
determin
safeti
msc
infus
patient
lung
diseas
secondari
goal
initi
estim
potenti
efficaci
msc
decreas
chronic
inflamm
associ
copd
thu
improv
pulmonari
function
qualiti
life
trial
recruit
patient
particip
us
site
month
interim
data
analysi
infusion
toxic
signific
advers
event
report
notabl
signific
decreas
circul
inflammatori
marker
creactiv
protein
commonli
elev
copd
patient
note
treat
patient
trend
toward
improv
qualiti
life
indic
trial
end
fall
result
forthcom
cf
autosom
recess
diseas
caus
mutat
gene
encod
cf
transmembran
conduct
regul
cftr
result
abnorm
ion
transport
across
respiratori
epithelium
lead
cf
lung
diseas
initi
cell
therapi
approach
cf
mous
model
base
concept
replac
defect
airway
epitheli
cell
wildtyp
donor
cell
contain
correct
cftr
gene
howev
rare
engraft
total
airway
epitheli
cell
airway
alveolar
epithelium
adult
bone
marrow
cord
bloodderiv
stem
cell
correspond
cftr
protein
express
found
figur
despit
util
naphthalen
denud
airway
epithelium
conceiv
enhanc
donor
cell
engraft
one
studi
intestin
engraft
also
assess
despit
rare
function
cftr
activ
detect
potenti
differ
measur
rectal
mucosa
recipi
mice
observ
remain
unexplain
difficult
reconcil
rare
engraft
cell
observ
physiolog
chang
potenti
differ
transplant
whole
marrow
onedayold
cftr
ko
mice
also
increas
number
donor
origin
cell
engraft
either
respiratori
intestin
epithelium
studi
suggest
system
administr
adult
bone
marrow
cord
bloodderiv
progenitor
cell
result
signific
structur
engraft
cftrexpress
cell
either
airway
intestin
epithelium
mous
model
although
yet
investig
cf
mous
model
sever
recent
studi
also
found
low
level
airway
epitheli
engraft
follow
direct
airway
administr
donor
marrowderiv
cell
mice
overal
observ
suggest
unless
signific
advanc
made
understand
mechan
cell
recruit
airway
epithelium
induc
undergo
phenotyp
convers
function
airway
epitheli
cell
correct
cf
lung
diseas
structur
engraft
adult
marrow
cord
bloodderiv
stem
cell
like
present
contrast
cf
lung
diseas
character
chronic
neutrophil
airway
inflamm
high
express
multipl
proinflammatori
cytokin
potenti
therapeut
role
msc
abat
inflamm
cf
lung
diseas
suggest
howev
avail
inform
concern
immunomodulatori
effect
msc
cf
lung
would
seem
promis
area
studi
asthma
character
revers
airflow
obstruct
hyperrespons
airway
smooth
muscl
agonist
airway
inflamm
case
asthma
patient
remain
symptomat
control
avail
medic
includ
corticosteroid
bronchodil
howev
approxim
asthmat
refractori
convent
treatment
suffer
substanti
morbid
mortal
abil
msc
modul
immun
system
led
increas
interest
use
msc
potenti
therapeut
modal
sever
refractori
asthma
sever
laboratori
demonstr
msc
amelior
allerg
airway
inflamm
mice
howev
optim
dose
rout
administr
time
administr
longev
msc
effect
yet
known
pulmonari
hypertens
ph
diseas
character
pulmonari
vascular
remodel
result
pulmonari
arteri
obstruct
turn
lead
elev
pulmonari
arteri
pressur
rightheart
dysfunct
ultim
progress
respiratori
failur
mscsbase
therapi
explor
potenti
therapeut
modal
devast
diseas
sever
rodent
model
ph
avail
commonli
use
involv
administr
monocrotalin
mct
exposur
chronic
hypoxia
systemat
intratrach
msc
administr
attenu
mctinduc
increas
pulmonari
arteri
pressur
improv
pulmonari
vascular
resist
protect
effect
msc
model
occur
even
cell
administ
system
day
follow
mct
administr
msc
express
sever
growth
factor
includ
vascular
endotheli
growth
factor
promot
neovascular
might
one
mechan
msc
protect
develop
ph
epc
transduc
express
proangiogen
factor
endotheli
nitric
oxid
synthetas
eno
inhibitor
smooth
muscl
cell
prolifer
calcitonin
gene
relat
peptid
improv
right
ventricl
function
number
studi
mice
dog
demonstr
role
exogen
administ
epc
vasculogenesi
vascular
repair
experiment
model
pulmonari
hypertens
epc
also
preferenti
local
area
injur
lung
follow
system
administr
may
also
paracrin
effect
decreas
inflamm
two
pilot
trial
autolog
epc
administr
primari
pulmonari
hypertens
conduct
zhejiang
univers
hangzhou
china
adult
pediatr
patient
demonstr
increas
minut
walk
capac
improv
hemodynam
variabl
includ
mean
pulmonari
arteri
pressur
pulmonari
vascular
resist
cardiac
output
week
system
administr
autolog
epc
convent
therapi
compar
patient
receiv
convent
therapi
alon
importantli
advers
effect
epc
administr
note
although
long
term
followup
pend
therapeut
trial
administr
autolog
epc
transduc
express
eno
patient
pulmonari
hypertens
pulmonari
hypertens
cell
therapi
phacet
trial
initi
st
michael
hospit
toronto
jewish
gener
hospit
montreal
march
phacet
trial
complet
enrol
first
dosepanel
three
patient
receiv
total
million
earli
growth
epc
transfect
overexpress
human
eno
panel
three
patient
receiv
million
cell
panel
inform
courtesi
duncan
stewart
md
frcpc
cell
deliveri
procedur
well
toler
safeti
concern
notabl
first
patient
show
remark
reduct
total
pulmonari
vascular
resist
pvr
cours
day
deliveri
period
might
repres
effect
increas
releas
engin
epc
within
pulmonari
microcircul
trial
data
safeti
monitor
board
approv
move
panel
call
total
million
cell
divid
dose
day
complet
third
dose
panel
follow
enrol
addit
three
patient
highest
toler
cell
dose
provid
suffici
support
move
forward
design
random
control
trial
assess
potenti
efficaci
cell
therapi
approach
pah
addit
possibl
endogen
lung
progenitor
cell
function
cancer
stem
cell
bone
marrowderiv
circul
msc
epc
fibrocyt
may
contribut
develop
primari
metastat
lung
malign
mice
part
provid
support
stroma
cancer
andor
particip
tumor
vascular
contrast
msc
epc
demonstr
home
area
tumor
develop
epc
msc
well
hsc
engin
releas
antitumor
proapoptot
agent
util
suppress
tumor
growth
mous
tumor
model
cell
base
therapi
may
thu
power
new
tool
lung
cancer
parallel
increas
number
circul
epc
also
portend
wors
surviv
among
non
small
cell
lung
cancer
thu
circul
stem
progenitor
cell
may
serv
use
biomark
lung
cancer
respons
therapi
recent
focu
explor
cultur
system
bioengin
approach
gener
function
lung
tissu
ex
vivo
vivo
approach
increasingli
success
util
regener
tissu
includ
skin
vasculatur
cartilag
bone
notabl
msc
isol
amniot
fluid
umbil
cord
blood
adipos
tissu
bone
marrow
seed
biodegrad
polyglycol
acid
biosynthet
scaffold
gener
tracheal
cartilag
use
repair
congenit
tracheal
defect
also
tendon
tissu
use
congenit
diaphragmat
defect
studi
anim
model
recent
clinic
investig
suggest
safeti
efficaci
clinic
trial
neonat
congenit
tracheal
diaphragmat
defect
plan
recent
approach
result
success
clinic
use
bioengin
airway
complex
threedimension
architectur
lung
make
engin
function
lung
parenchyma
ex
vivo
difficult
task
studi
vitro
vivo
util
mix
fetal
lung
cell
cultur
threedimension
glycosaminoglycan
gag
type
scaffold
result
format
alveolarlik
structur
scaffold
stimul
murin
fetal
lung
cell
polym
scaffold
differ
isoform
fibroblast
growth
factor
result
differ
pattern
develop
demonstr
power
threedimension
cultur
system
evalu
lung
develop
repair
fetal
rat
lung
cell
cultur
biodegrad
gelatin
spong
subsequ
inject
normal
rat
lung
induc
format
branch
saccul
epitheli
structur
reminisc
lung
parenchym
architectur
mix
fetal
murin
epitheli
cell
admix
matrigel
inject
subcutan
abdomin
wall
adult
mice
demonstr
cell
express
prosurfact
protein
c
one
week
studi
demonstr
potenti
vivo
lung
tissu
gener
util
mix
popul
fetal
lung
cell
howev
use
fetal
lung
cell
practic
approach
lung
tissu
engin
stem
progenitor
cell
practic
option
howev
studi
yet
evalu
whether
stem
progenitor
cell
isol
adult
bone
marrow
cord
blood
sourc
also
compar
form
airway
alveolarlik
structur
cultiv
threedimension
matrix
scaffold
materi
whether
stem
progenitor
cell
cultur
fashion
util
function
lung
regener
vivo
popul
cell
describ
adult
lung
somat
progenitor
cell
isol
adult
sheep
lung
cultur
synthet
polym
construct
result
express
airway
alveolar
epitheli
marker
cell
structur
resembl
lung
airway
parenchyma
develop
impregn
construct
implant
subcutan
nude
mice
insert
wound
caviti
follow
wedg
lung
resect
sheep
adiposederiv
msc
cultur
ex
vivo
sheet
polyglycol
acid
appli
wound
edg
follow
lung
volum
reduct
surgeri
rat
acceler
alveolar
vascular
regener
success
engin
portion
bronchu
subsequ
transplant
patient
bronchial
stenosi
also
report
particular
studi
autolog
bone
marrowderiv
msc
cultur
differenti
chrondroblast
prior
seed
onto
decellular
allograft
section
bronchu
along
patient
epitheli
cell
appli
appropri
growth
factor
physic
forc
function
bronchu
result
util
transplant
studi
demonstr
msc
stem
cell
popul
util
ex
vivo
tissu
bioengin
herald
potenti
new
era
lung
transplant
continu
rapid
accumul
data
anim
model
clinic
trial
suggest
cellbas
therapi
use
adult
tissuederiv
stemprogenitor
cell
may
potenti
therapeut
strategi
lung
repair
remodel
injuri
sourc
cell
ex
vivo
lung
tissu
engin
parallel
understand
role
endogen
lung
progenitor
cell
provid
insight
mechan
lung
develop
repair
injuri
may
also
provid
novel
therapeut
strategi
hope
new
research
program
provid
understand
mechan
repair
lung
injuri
provid
sound
scientif
basi
therapeut
use
stem
cell
therapi
lung
diseas
embryon
stem
cell
esc
effect
manipul
vitro
differenti
type
alveolar
epitheli
cell
use
lung
develop
cell
signal
pathway
guid
esc
differenti
fibroblast
growth
pro
spc
prosurfact
protein
c
schemat
illustr
rang
vitro
immunemodul
effect
describ
mesenchym
stem
cell
msc
dc
dendrit
cell
hgf
hepatocyt
growth
factor
ido
indoleamin
interferon
ig
immunoglobulin
il
interleukin
receptor
antagonist
mac
macrophag
nk
natur
killer
prostaglandin
stemcel
deriv
factor
tumor
necrosi
transform
growth
tlr
tolllik
receptor
vegf
vascular
endotheli
growth
factor
